Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction

Objectives The objective of the investigation is to examine the long term efficacy, safety, and predictability of ICL-V4c implantation for high and super-high myopic patients in order to provide reliable guidance for the selection of refractive surgical procedures.Methods We reviewed 125 eyes from 6...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Wan, Li Chen, Peiyuan He, Ran Wei, Ke Ma, Hongbo Yin, Jing Tang, Ying-ping Deng
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2024.2448282
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587242432888832
author Qi Wan
Li Chen
Peiyuan He
Ran Wei
Ke Ma
Hongbo Yin
Jing Tang
Ying-ping Deng
author_facet Qi Wan
Li Chen
Peiyuan He
Ran Wei
Ke Ma
Hongbo Yin
Jing Tang
Ying-ping Deng
author_sort Qi Wan
collection DOAJ
description Objectives The objective of the investigation is to examine the long term efficacy, safety, and predictability of ICL-V4c implantation for high and super-high myopic patients in order to provide reliable guidance for the selection of refractive surgical procedures.Methods We reviewed 125 eyes from 64 patients who implanted ICL-V4c at the Refractive Surgery Center of West China Hospital in Chengdu, China, between May 2015 and January 2017. These eyes were divided into two groups based on their preoperative spherical equivalent (SE) degree: high myopia (≥ −10D) and super-high myopia groups (< −10D). We followed up with the patients over 5 years and evaluated several parameters, including uncorrected visual acuity (UDVA), corrected visual acuity (CDVA), axial length (AL), refractive error, endothelial cell density (ECD), intraocular pressure (IOP), white-to-white distance (WTW), and vault.Results The efficacy indices of ICL-V4c implantation in high and super-high myopia groups were 0.91 ± 0.23 and 0.80 ± 0.25, respectively at 5 years after operation. Compared to high myopia group, the efficacy index of super-high myopia was obviously decreased (p = 0.020) and the △AL of super-high myopia was significantly increased (p = 0.001). The mean safety indices were 1.10 ± 0.15 and 1.10 ± 0.21 respectively in high and super-high myopia groups (p = 0.850). At the 5-year mark, 11.67% vs 20.00% (High vs Super-high) of eyes were within ±0.50 D (Spherical Equivalent), and 75.00% vs 70.77% (High vs Super-high) of eyes were within ±2.00 D. No significant difference of ECD was found in the high (2823.45 ± 274.75 cells/mm2) and super-high myopia (2856.71 ± 323.53cells/mm2) at the visit of 5 years. Compared to baseline, we observed a significant increase in IOP at the 1-week follow-up, which decreased significantly at the one-month visit. Furthermore, there was a significant difference of vault between the high and super-high groups at 1-month (p = 0.042) and 5-year (p = 0.002) after surgery.Conclusions ICL-V4c implantation is effective, safe, and stable for correcting high and super-high myopia. However, ophthalmologists need to be aware of the potential for greater myopia regression in super-high myopic patients, as well as the increase in axial length and associated fundus complications.
format Article
id doaj-art-b45a9e91a43a41e8b4ae2c8fd68fed43
institution Kabale University
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-b45a9e91a43a41e8b4ae2c8fd68fed432025-01-24T16:02:21ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2024.2448282Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correctionQi Wan0Li Chen1Peiyuan He2Ran Wei3Ke Ma4Hongbo Yin5Jing Tang6Ying-ping Deng7Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaDepartment of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaDepartment of Health Management &amp; Institute of Health Management, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu City, ChinaDepartment of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaDepartment of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaDepartment of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaDepartment of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaDepartment of Ophthalmology, West China Hospital of Sichuan University, Chengdu City, ChinaObjectives The objective of the investigation is to examine the long term efficacy, safety, and predictability of ICL-V4c implantation for high and super-high myopic patients in order to provide reliable guidance for the selection of refractive surgical procedures.Methods We reviewed 125 eyes from 64 patients who implanted ICL-V4c at the Refractive Surgery Center of West China Hospital in Chengdu, China, between May 2015 and January 2017. These eyes were divided into two groups based on their preoperative spherical equivalent (SE) degree: high myopia (≥ −10D) and super-high myopia groups (< −10D). We followed up with the patients over 5 years and evaluated several parameters, including uncorrected visual acuity (UDVA), corrected visual acuity (CDVA), axial length (AL), refractive error, endothelial cell density (ECD), intraocular pressure (IOP), white-to-white distance (WTW), and vault.Results The efficacy indices of ICL-V4c implantation in high and super-high myopia groups were 0.91 ± 0.23 and 0.80 ± 0.25, respectively at 5 years after operation. Compared to high myopia group, the efficacy index of super-high myopia was obviously decreased (p = 0.020) and the △AL of super-high myopia was significantly increased (p = 0.001). The mean safety indices were 1.10 ± 0.15 and 1.10 ± 0.21 respectively in high and super-high myopia groups (p = 0.850). At the 5-year mark, 11.67% vs 20.00% (High vs Super-high) of eyes were within ±0.50 D (Spherical Equivalent), and 75.00% vs 70.77% (High vs Super-high) of eyes were within ±2.00 D. No significant difference of ECD was found in the high (2823.45 ± 274.75 cells/mm2) and super-high myopia (2856.71 ± 323.53cells/mm2) at the visit of 5 years. Compared to baseline, we observed a significant increase in IOP at the 1-week follow-up, which decreased significantly at the one-month visit. Furthermore, there was a significant difference of vault between the high and super-high groups at 1-month (p = 0.042) and 5-year (p = 0.002) after surgery.Conclusions ICL-V4c implantation is effective, safe, and stable for correcting high and super-high myopia. However, ophthalmologists need to be aware of the potential for greater myopia regression in super-high myopic patients, as well as the increase in axial length and associated fundus complications.https://www.tandfonline.com/doi/10.1080/07853890.2024.2448282High myopiasuper-high myopiaposterior chamber phakicimplantationICL-V4c
spellingShingle Qi Wan
Li Chen
Peiyuan He
Ran Wei
Ke Ma
Hongbo Yin
Jing Tang
Ying-ping Deng
Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
Annals of Medicine
High myopia
super-high myopia
posterior chamber phakic
implantation
ICL-V4c
title Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
title_full Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
title_fullStr Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
title_full_unstemmed Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
title_short Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
title_sort five years comparation of efficacy and safety after icl v4c implantation for high and super high myopia correction
topic High myopia
super-high myopia
posterior chamber phakic
implantation
ICL-V4c
url https://www.tandfonline.com/doi/10.1080/07853890.2024.2448282
work_keys_str_mv AT qiwan fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT lichen fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT peiyuanhe fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT ranwei fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT kema fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT hongboyin fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT jingtang fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection
AT yingpingdeng fiveyearscomparationofefficacyandsafetyaftericlv4cimplantationforhighandsuperhighmyopiacorrection